ScholarIQanswers from OpenAlex

Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk

PaperCitations, authors & open-access status

Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk have?

ScholarIQcitation count

Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk has 118 citations in the OpenAlex counts ScholarIQ stores.

When was Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk published?

ScholarIQyear

Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk has 2019 year in the ScholarIQ index.

What is the open-access status of Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk?

ScholarIQoa status

Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk has closed oa status in the ScholarIQ index.

What is the DOI of Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk?

ScholarIQdoi

The DOI for Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk is on the source record.

What is the PMID of Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk?

ScholarIQpmid

The PMID for Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk is on the source record.

What is the OpenAlex record for Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk?

ScholarIQopenalex

The OpenAlex for Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial